Article Text

Characterisation and growth outcomes of children with Insulin-like Growth Factor-1 deficiency in idiopathic short stature
  1. N Keshavan,
  2. A Dlakavu,
  3. D Dunger,
  4. A Thankamony
  1. Department of Paediatrics, University of Cambridge, Cambridge, UK


Background/aims Children with idiopathic short stature (ISS) constitute a heterogenous group. Recombinant IGF-I (rhIGF-I) have been licensed for the treatment of severe short stature (height <−3 standard deviation scores (SDS)) in ISS children with low IGF-I levels (IGF-I<−2 SDS). However, children with low IGF-I levels remain poorly characterised. We aim to characterise the clinical features and growth outcomes of ISS children with low IGF-I levels in a tertiary paediatric endocrinology clinic.

Methods Children with ISS were identified by a retrospective review of patients who underwent GH provocation tests during 2000-2011 using the criteria (i) pre-pubertal state (ii) age <13 years in girls, and <14 years in boys (iii) height <−2 SDS (iv) absence of organic causes of pituitary dysfunction and (v) peak Growth Hormone levels (GH) > 8 µg/L (vi) birth weight >−2 SDS.

Results We identified 11 (47.8%) children with low IGF-I levels among 23 ISS children. They had a lower height SDS adjusted for parental height (p=0.002) and weight SDS (p=0.005) as compared with ISS children with normal IGF-I levels (table 1). These children also had increased peak stimulated GH levels (p=0.001). However, abnormally high levels (>24µg/L) were not observed. Of the 9 children with low IGF-I levels, who had subsequent IGF-I measurements, 5 increased their levels to >−2 SDS spontaneously (figure 1). Among the 7 of these children who were followed up to puberty, 4 improved their height to >−2 SDS without any treatments. Six of the 11 children with low IGF-I levels (54.5%), had a height of <−3 SDS and were eligible for rhIGF-I therapy by the current guidelines (table 1 and figure 1).

Abstract G187 Figure 1

Subsequent IGF-Is measured during follow up in the 11 ISS children with low baseline IGF-I levels. Dashed lines indicate improvement in IGF-I, solid lines indicate persistently low IGF-I.

Abstract G187 Table 1

Baseline data of children with idiopathic short staure. Data presented as medians, range(min,max). P values calculated according to Mann-Whitney Test with significant values in bold.

Conclusion We found that 47.8% of ISS children had low IGF-I levels. They were shorter and weighed less than other ISS children and exhibited GH resistance. However, alterations in GH/IGF-I axis were transient in almost half of these children, leading to increases in height SDS and IGF-I SDS with time. Improvements in nutrition or onset of puberty may explain the spontaneous increases in IGF-I levels. Persistently low IGF-I levels may be used to select children for further evaluation including molecular analysis in the absence of classical features of GH resistance.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.